Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
Identifieur interne : 003B77 ( Main/Exploration ); précédent : 003B76; suivant : 003B78Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
Auteurs : Kay Lee Park ; Robert J. Goldberg ; Frederick A. Anderson ; José L Pez-Send N [Espagne] ; Gilles Montalescot [France] ; David Brieger [Australie] ; Kim A. Eagle ; Allison Wyman ; Joel M. GoreSource :
- The American journal of medicine [ 1555-7162 ] ; 2014.
Descripteurs français
- KwdFr :
- Administration par voie intraveineuse, Administration par voie orale, Adolescent, Adulte, Adulte d'âge moyen, Analyse multivariée, Antagonistes bêta-adrénergiques (administration et posologie), Antagonistes bêta-adrénergiques (usage thérapeutique), Calendrier d'administration des médicaments, Enregistrements, Femelle, Humains, Infarctus du myocarde (), Infarctus du myocarde (diagnostic), Infarctus du myocarde (mortalité), Infarctus du myocarde (traitement médicamenteux), Jeune adulte, Modèles logistiques, Mortalité hospitalière, Mâle, Résultat thérapeutique, Score de propension, Sujet âgé, Sujet âgé de 80 ans ou plus, Électrocardiographie.
- MESH :
- administration et posologie : Antagonistes bêta-adrénergiques.
- diagnostic : Infarctus du myocarde.
- mortalité : Infarctus du myocarde.
- traitement médicamenteux : Infarctus du myocarde.
- usage thérapeutique : Antagonistes bêta-adrénergiques.
- Administration par voie intraveineuse, Administration par voie orale, Adolescent, Adulte, Adulte d'âge moyen, Analyse multivariée, Calendrier d'administration des médicaments, Enregistrements, Femelle, Humains, Infarctus du myocarde, Jeune adulte, Modèles logistiques, Mortalité hospitalière, Mâle, Résultat thérapeutique, Score de propension, Sujet âgé, Sujet âgé de 80 ans ou plus, Électrocardiographie.
English descriptors
- KwdEn :
- Administration, Intravenous, Administration, Oral, Adolescent, Adrenergic beta-Antagonists (administration & dosage), Adrenergic beta-Antagonists (therapeutic use), Adult, Aged, Aged, 80 and over, Drug Administration Schedule, Electrocardiography, Female, Hospital Mortality, Humans, Logistic Models, Male, Middle Aged, Multivariate Analysis, Myocardial Infarction (complications), Myocardial Infarction (diagnosis), Myocardial Infarction (drug therapy), Myocardial Infarction (mortality), Propensity Score, Registries, Treatment Outcome, Young Adult.
- MESH :
- chemical , administration & dosage : Adrenergic beta-Antagonists.
- chemical , therapeutic use : Adrenergic beta-Antagonists.
- complications : Myocardial Infarction.
- diagnosis : Myocardial Infarction.
- drug therapy : Myocardial Infarction.
- mortality : Myocardial Infarction.
- Administration, Intravenous, Administration, Oral, Adolescent, Adult, Aged, Aged, 80 and over, Drug Administration Schedule, Electrocardiography, Female, Hospital Mortality, Humans, Logistic Models, Male, Middle Aged, Multivariate Analysis, Propensity Score, Registries, Treatment Outcome, Young Adult.
Abstract
Current guidelines recommend early oral beta-blocker administration in the management of acute coronary syndromes for patients who are not at high risk of complications.
DOI: 10.1016/j.amjmed.2014.02.009
PubMed: 24561113
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003756
- to stream PubMed, to step Curation: 003642
- to stream PubMed, to step Checkpoint: 003642
- to stream Ncbi, to step Merge: 001807
- to stream Ncbi, to step Curation: 001807
- to stream Ncbi, to step Checkpoint: 001807
- to stream Main, to step Merge: 003C25
- to stream Main, to step Curation: 003B77
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).</title><author><name sortKey="Park, Kay Lee" sort="Park, Kay Lee" uniqKey="Park K" first="Kay Lee" last="Park">Kay Lee Park</name><affiliation><nlm:affiliation>Center for Outcomes Research, University of Massachusetts Medical School, Worcester.</nlm:affiliation><wicri:noCountry code="subField">Worcester</wicri:noCountry></affiliation></author><author><name sortKey="Goldberg, Robert J" sort="Goldberg, Robert J" uniqKey="Goldberg R" first="Robert J" last="Goldberg">Robert J. Goldberg</name><affiliation><nlm:affiliation>Center for Outcomes Research, University of Massachusetts Medical School, Worcester.</nlm:affiliation><wicri:noCountry code="subField">Worcester</wicri:noCountry></affiliation></author><author><name sortKey="Anderson, Frederick A" sort="Anderson, Frederick A" uniqKey="Anderson F" first="Frederick A" last="Anderson">Frederick A. Anderson</name><affiliation><nlm:affiliation>Center for Outcomes Research, University of Massachusetts Medical School, Worcester.</nlm:affiliation><wicri:noCountry code="subField">Worcester</wicri:noCountry></affiliation></author><author><name sortKey="L Pez Send N, Jose" sort="L Pez Send N, Jose" uniqKey="L Pez Send N J" first="José" last="L Pez-Send N">José L Pez-Send N</name><affiliation wicri:level="3"><nlm:affiliation>Cardiology Department, Hospital Universitario La Paz, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Cardiology Department, Hospital Universitario La Paz, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Montalescot, Gilles" sort="Montalescot, Gilles" uniqKey="Montalescot G" first="Gilles" last="Montalescot">Gilles Montalescot</name><affiliation wicri:level="3"><nlm:affiliation>Institute of Cardiology, Pitié-Salpêtrière Hospital, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institute of Cardiology, Pitié-Salpêtrière Hospital, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Brieger, David" sort="Brieger, David" uniqKey="Brieger D" first="David" last="Brieger">David Brieger</name><affiliation wicri:level="1"><nlm:affiliation>Concord Repatriation General Hospital, Coronary Care Unit, Concord, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Concord Repatriation General Hospital, Coronary Care Unit, Concord, New South Wales</wicri:regionArea><wicri:noRegion>New South Wales</wicri:noRegion></affiliation></author><author><name sortKey="Eagle, Kim A" sort="Eagle, Kim A" uniqKey="Eagle K" first="Kim A" last="Eagle">Kim A. Eagle</name><affiliation><nlm:affiliation>University of Michigan Health System, Ann Arbor.</nlm:affiliation><wicri:noCountry code="subField">Ann Arbor</wicri:noCountry></affiliation></author><author><name sortKey="Wyman, Allison" sort="Wyman, Allison" uniqKey="Wyman A" first="Allison" last="Wyman">Allison Wyman</name><affiliation><nlm:affiliation>Center for Outcomes Research, University of Massachusetts Medical School, Worcester.</nlm:affiliation><wicri:noCountry code="subField">Worcester</wicri:noCountry></affiliation></author><author><name sortKey="Gore, Joel M" sort="Gore, Joel M" uniqKey="Gore J" first="Joel M" last="Gore">Joel M. Gore</name><affiliation><nlm:affiliation>Center for Outcomes Research, University of Massachusetts Medical School, Worcester. Electronic address: joel.gore@umassmemorial.org.</nlm:affiliation><wicri:noCountry code="subField">Worcester</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24561113</idno><idno type="pmid">24561113</idno><idno type="doi">10.1016/j.amjmed.2014.02.009</idno><idno type="wicri:Area/PubMed/Corpus">003756</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003756</idno><idno type="wicri:Area/PubMed/Curation">003642</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003642</idno><idno type="wicri:Area/PubMed/Checkpoint">003642</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003642</idno><idno type="wicri:Area/Ncbi/Merge">001807</idno><idno type="wicri:Area/Ncbi/Curation">001807</idno><idno type="wicri:Area/Ncbi/Checkpoint">001807</idno><idno type="wicri:Area/Main/Merge">003C25</idno><idno type="wicri:Area/Main/Curation">003B77</idno><idno type="wicri:Area/Main/Exploration">003B77</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).</title><author><name sortKey="Park, Kay Lee" sort="Park, Kay Lee" uniqKey="Park K" first="Kay Lee" last="Park">Kay Lee Park</name><affiliation><nlm:affiliation>Center for Outcomes Research, University of Massachusetts Medical School, Worcester.</nlm:affiliation><wicri:noCountry code="subField">Worcester</wicri:noCountry></affiliation></author><author><name sortKey="Goldberg, Robert J" sort="Goldberg, Robert J" uniqKey="Goldberg R" first="Robert J" last="Goldberg">Robert J. Goldberg</name><affiliation><nlm:affiliation>Center for Outcomes Research, University of Massachusetts Medical School, Worcester.</nlm:affiliation><wicri:noCountry code="subField">Worcester</wicri:noCountry></affiliation></author><author><name sortKey="Anderson, Frederick A" sort="Anderson, Frederick A" uniqKey="Anderson F" first="Frederick A" last="Anderson">Frederick A. Anderson</name><affiliation><nlm:affiliation>Center for Outcomes Research, University of Massachusetts Medical School, Worcester.</nlm:affiliation><wicri:noCountry code="subField">Worcester</wicri:noCountry></affiliation></author><author><name sortKey="L Pez Send N, Jose" sort="L Pez Send N, Jose" uniqKey="L Pez Send N J" first="José" last="L Pez-Send N">José L Pez-Send N</name><affiliation wicri:level="3"><nlm:affiliation>Cardiology Department, Hospital Universitario La Paz, Madrid, Spain.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Cardiology Department, Hospital Universitario La Paz, Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Montalescot, Gilles" sort="Montalescot, Gilles" uniqKey="Montalescot G" first="Gilles" last="Montalescot">Gilles Montalescot</name><affiliation wicri:level="3"><nlm:affiliation>Institute of Cardiology, Pitié-Salpêtrière Hospital, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Institute of Cardiology, Pitié-Salpêtrière Hospital, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Brieger, David" sort="Brieger, David" uniqKey="Brieger D" first="David" last="Brieger">David Brieger</name><affiliation wicri:level="1"><nlm:affiliation>Concord Repatriation General Hospital, Coronary Care Unit, Concord, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Concord Repatriation General Hospital, Coronary Care Unit, Concord, New South Wales</wicri:regionArea><wicri:noRegion>New South Wales</wicri:noRegion></affiliation></author><author><name sortKey="Eagle, Kim A" sort="Eagle, Kim A" uniqKey="Eagle K" first="Kim A" last="Eagle">Kim A. Eagle</name><affiliation><nlm:affiliation>University of Michigan Health System, Ann Arbor.</nlm:affiliation><wicri:noCountry code="subField">Ann Arbor</wicri:noCountry></affiliation></author><author><name sortKey="Wyman, Allison" sort="Wyman, Allison" uniqKey="Wyman A" first="Allison" last="Wyman">Allison Wyman</name><affiliation><nlm:affiliation>Center for Outcomes Research, University of Massachusetts Medical School, Worcester.</nlm:affiliation><wicri:noCountry code="subField">Worcester</wicri:noCountry></affiliation></author><author><name sortKey="Gore, Joel M" sort="Gore, Joel M" uniqKey="Gore J" first="Joel M" last="Gore">Joel M. Gore</name><affiliation><nlm:affiliation>Center for Outcomes Research, University of Massachusetts Medical School, Worcester. Electronic address: joel.gore@umassmemorial.org.</nlm:affiliation><wicri:noCountry code="subField">Worcester</wicri:noCountry></affiliation></author></analytic><series><title level="j">The American journal of medicine</title><idno type="eISSN">1555-7162</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Intravenous</term><term>Administration, Oral</term><term>Adolescent</term><term>Adrenergic beta-Antagonists (administration & dosage)</term><term>Adrenergic beta-Antagonists (therapeutic use)</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Drug Administration Schedule</term><term>Electrocardiography</term><term>Female</term><term>Hospital Mortality</term><term>Humans</term><term>Logistic Models</term><term>Male</term><term>Middle Aged</term><term>Multivariate Analysis</term><term>Myocardial Infarction (complications)</term><term>Myocardial Infarction (diagnosis)</term><term>Myocardial Infarction (drug therapy)</term><term>Myocardial Infarction (mortality)</term><term>Propensity Score</term><term>Registries</term><term>Treatment Outcome</term><term>Young Adult</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Administration par voie intraveineuse</term><term>Administration par voie orale</term><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Analyse multivariée</term><term>Antagonistes bêta-adrénergiques (administration et posologie)</term><term>Antagonistes bêta-adrénergiques (usage thérapeutique)</term><term>Calendrier d'administration des médicaments</term><term>Enregistrements</term><term>Femelle</term><term>Humains</term><term>Infarctus du myocarde ()</term><term>Infarctus du myocarde (diagnostic)</term><term>Infarctus du myocarde (mortalité)</term><term>Infarctus du myocarde (traitement médicamenteux)</term><term>Jeune adulte</term><term>Modèles logistiques</term><term>Mortalité hospitalière</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Score de propension</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Électrocardiographie</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Adrenergic beta-Antagonists</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenergic beta-Antagonists</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antagonistes bêta-adrénergiques</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Myocardial Infarction</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Myocardial Infarction</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infarctus du myocarde</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Myocardial Infarction</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Myocardial Infarction</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Infarctus du myocarde</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infarctus du myocarde</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antagonistes bêta-adrénergiques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Intravenous</term><term>Administration, Oral</term><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Aged, 80 and over</term><term>Drug Administration Schedule</term><term>Electrocardiography</term><term>Female</term><term>Hospital Mortality</term><term>Humans</term><term>Logistic Models</term><term>Male</term><term>Middle Aged</term><term>Multivariate Analysis</term><term>Propensity Score</term><term>Registries</term><term>Treatment Outcome</term><term>Young Adult</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Administration par voie intraveineuse</term><term>Administration par voie orale</term><term>Adolescent</term><term>Adulte</term><term>Adulte d'âge moyen</term><term>Analyse multivariée</term><term>Calendrier d'administration des médicaments</term><term>Enregistrements</term><term>Femelle</term><term>Humains</term><term>Infarctus du myocarde</term><term>Jeune adulte</term><term>Modèles logistiques</term><term>Mortalité hospitalière</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Score de propension</term><term>Sujet âgé</term><term>Sujet âgé de 80 ans ou plus</term><term>Électrocardiographie</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Current guidelines recommend early oral beta-blocker administration in the management of acute coronary syndromes for patients who are not at high risk of complications.</div></front></TEI><affiliations><list><country><li>Australie</li><li>Espagne</li><li>France</li></country><region><li>Communauté de Madrid</li><li>Île-de-France</li></region><settlement><li>Madrid</li><li>Paris</li></settlement></list><tree><noCountry><name sortKey="Anderson, Frederick A" sort="Anderson, Frederick A" uniqKey="Anderson F" first="Frederick A" last="Anderson">Frederick A. Anderson</name><name sortKey="Eagle, Kim A" sort="Eagle, Kim A" uniqKey="Eagle K" first="Kim A" last="Eagle">Kim A. Eagle</name><name sortKey="Goldberg, Robert J" sort="Goldberg, Robert J" uniqKey="Goldberg R" first="Robert J" last="Goldberg">Robert J. Goldberg</name><name sortKey="Gore, Joel M" sort="Gore, Joel M" uniqKey="Gore J" first="Joel M" last="Gore">Joel M. Gore</name><name sortKey="Park, Kay Lee" sort="Park, Kay Lee" uniqKey="Park K" first="Kay Lee" last="Park">Kay Lee Park</name><name sortKey="Wyman, Allison" sort="Wyman, Allison" uniqKey="Wyman A" first="Allison" last="Wyman">Allison Wyman</name></noCountry><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="L Pez Send N, Jose" sort="L Pez Send N, Jose" uniqKey="L Pez Send N J" first="José" last="L Pez-Send N">José L Pez-Send N</name></region></country><country name="France"><region name="Île-de-France"><name sortKey="Montalescot, Gilles" sort="Montalescot, Gilles" uniqKey="Montalescot G" first="Gilles" last="Montalescot">Gilles Montalescot</name></region></country><country name="Australie"><noRegion><name sortKey="Brieger, David" sort="Brieger, David" uniqKey="Brieger D" first="David" last="Brieger">David Brieger</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B77 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003B77 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24561113
|texte= Beta-blocker use in ST-segment elevation myocardial infarction in the reperfusion era (GRACE).
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24561113" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |